Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hadley

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|March 19, 1993
Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulantsF D King, M S Hadley, K T Joiner, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Identification of a potent and selective 5-HT1B receptor antagonistPaul A Wyman, Howard R Marshall, Sean T Flynn, et al.
Journal of Medicinal Chemistry|January 22, 1998
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostereS M Bromidge, F Brown, F Cassidy, et al.
Bioorganic & Medicinal Chemistry|September 26, 2000
Evaluation of a series of anticonvulsant 1,2,3,4-tetrahydroisoquinolinyl-benzamidesW N Chan, M S Hadley, J D Harling, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptorR A Porter, W N Chan, S Coulton, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptorK Y Avenell, I Boyfield, M C Coldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|March 19, 1993
Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulantsF D King, M S Hadley, K T Joiner, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Identification of a potent and selective 5-HT1B receptor antagonistPaul A Wyman, Howard R Marshall, Sean T Flynn, et al.
Journal of Medicinal Chemistry|January 22, 1998
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostereS M Bromidge, F Brown, F Cassidy, et al.
Bioorganic & Medicinal Chemistry|September 26, 2000
Evaluation of a series of anticonvulsant 1,2,3,4-tetrahydroisoquinolinyl-benzamidesW N Chan, M S Hadley, J D Harling, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptorR A Porter, W N Chan, S Coulton, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptorK Y Avenell, I Boyfield, M C Coldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Pageof 8